all report title image
  • Published On : Sep 2022
  • Code : CMI692
  • Industry : Medical Imaging
  • Pages : 155
  • Formats :

Technologies in the global small animal imaging market include magnetic resonance imaging (MRI), computed tomography (CT), optical imaging, ultrasound, nuclear imaging systems, photoacoustic imaging systems and magnetic particle imaging (MPI) systems. Nuclear imaging systems include Micro-PET (Positron emission tomography) systems, Micro-SPECT (Single-photon emission computed tomography) systems, and Trimodality (SPECT/PET/Computed Tomography) systems. Optical imaging systems include bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, and X-ray/optical imaging systems. With technological developments, scientists have successfully modified these devices to deliver enhanced imaging quality, providing scientists with better insights to research programs. Multimodal imaging devices, combination of PET, SPECT, MRI, and CT technologies, have contributed significantly in preclinical research. Research and development activities in drug development for chronic diseases such as cancer, arthritis, and others is expected to drive the demand for technologically advanced small animal imaging systems.

Global small animal imaging market is estimated to be valued at US$ 977.7 million in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period (2022-2030).

Figure 1. Global Small Animal Imaging Market Share (%), By Region, 2022

Small Animal Imaging  | Coherent Market Insights

Rising cases of chronic diseases such as cancer, diabetes, cardiovascular disease, and others creates a demand for personalized medicine which can be achieved using small animal imaging. This is expected to drive growth of the global small animal imaging market over the forecast period.

For instance, according to data published in the International Diabetes Federation (IDF) Diabetes Atlas Tenth edition 2021, in December 2021, it is estimated that around 537 million adults (20-79 years) were suffering from diabetes across the globe in 2021. The same source also estimates that the total number of people suffering from diabetes will rise to around 643 million by 2030 and 783 million by 2045, globally.

CMI table icon

Small Animal Imaging Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 977.7 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 7.1 % 2030 Value Projection: US$ 1,692.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Optical Imaging Systems (Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems X-Ray/Optical Imaging Systems), Nuclear Imaging Systems (Micro-PET (Positron Emission Tomography) Systems, Micro-SPECT (Single-Photon Emission Computed Tomography) Systems, Trimodality (SPECT/PET/CT) Systems), MRI (Magnetic Resonance Imaging) Systems, Ultrasound Systems, CT (Computed Tomography) Systems, Others (Photoacoustic Imaging Systems and Magnetic Particle Imaging (MPI) Systems, among others)
  • By Application: Monitoring Drug Treatment Response, Bio-distribution Studies, Cancer Cell Detection, Biomarkers, Others (Longitudinal Studies and Epigenetics, among others)
  • By End User: Biotechnology and Pharmaceutical Companies, Academic/ Research Institutes, Others (Contract Research Organizations, Laboratories, among others)
Companies covered:

Bruker, Aspect Imaging Ltd, TriFoil Imaging, LI-COR, Inc., FUJIFILM Holdings Corporation, Promega Corporation, Siemens Healthineers, Hallmarq Veterinary Imaging, Analytik Jena GmbH, Mediso Ltd., iThera Medical GmbH, MILabs B.V., Heska Corporation, Miltenyi Biotech GmbH, and PerkinElmer, Inc.

Growth Drivers:
  • Increasing incidence of chronic diseases such as diabetes, cancer, etc. and rising demand of personalized medicines for its treatment
  • Rapid research and development activities by market players
Restraints & Challenges:
  • High device development cost for small animal imaging equipment
  • Stringent regulatory scenario pertaining to the small animal imaging market 

Figure 2. Global Small Animal Imaging Market Value (US$ Mn), By Product Type, 2022

Small Animal Imaging  | Coherent Market Insights

Increasing R&D in the field of drug development and disease detection using small animal imaging systems is expected to drive market growth over the forecast period.

Small animal imaging requires animals to be injected with a radioactive biomolecule, targeting a key biomarker which controls the disease progression in case of cancer, sickle cell disease (SCD), and others. MRI, X-ray, and other imaging devices are used in development and characterization of imaging biomarkers which help to assess drug resistance and response.

Rapid research in the field of biomarkers and small animal imaging is expected to drive the growth of global small animal imaging market. For instance, according to an article published by the Blood Advances journal in September 2020, very late antigen-4 (VLA-4) has been identified as a non-invasive positron emission tomography (PET) imaging biomarker used to detect vaso-occlusive crises in case of sickle cell disease (SCD) in the U.S.

Global Small Animal Imaging Market – Impact of Coronavirus (Covid-19) Pandemic

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus) was first reported from Wuhan, China in December 2019, and was declared as a global pandemic by the World Health Organization (WHO), which designates this SARS-CoV-2 infection as novel Coronavirus (COVID-19). According to the Coronavirus (COVID-19), Weekly Epidemiological Update by the World Health Organization, COVID-19 has spread across the globe infecting over 541 million population leading to more than 6.3 million deaths as of June 26, 2022. The negative impact of COVID-19 on the healthcare domain is huge and it has significantly disrupted the healthcare industries’ entire supply chain, from raw materials to manufacturing and delivery. However, the COVID-19 pandemic had a positive impact on the overall growth of the small animal imaging market, owing to use of small animal imaging systems to develop new tools, vaccines, and treatments for COVID-19 patients. The supply and production of imaging products also increased due to the necessity for research and development activities during the COVID-19 pandemic.

For instance, according to a report published by the Francis Crick Institute in the U.K., in July 2020, animal research and development activities are expected to increase during the COVID-19 pandemic. The pandemic has brought attention to the necessity of animal research in the development of safe and effective vaccines. The developments has also paved the way for new ways of working, such as a greater emphasis on bioinformatics and enhanced data sharing.

Global Small Animal Imaging Market - Restraints

High device development cost for small animal imaging equipment and stringent regulatory scenario pertaining to the small animal imaging market are the factors that are expected to hinder growth of the global small animal imaging market over the forecast period.

Clinical viability of molecular imaging devices require regulatory approval for imaging probes by the U.S. FDA and reimbursement from insurance carriers and the Centers for Medicare and Medicaid Services (CMS). This makes the overall approval process long, complicated, and expensive, as the molecular imaging devices have a large number of probes and technologies associated, all seeking prerequisite approval and reimbursement before actual launch. Hence, these regulations and approval requirements makes the market highly cost intensive, restricting the entry of new players, as well as the sales of the imaging devices.

Key Players

Major players operating in the global small animal imaging market include Bruker, Aspect Imaging Ltd, TriFoil Imaging, LI-COR, Inc., FUJIFILM Holdings Corporation, Promega Corporation, Siemens Healthineers, Hallmarq Veterinary Imaging, Analytik Jena GmbH, Mediso Ltd., iThera Medical GmbH, MILabs B.V., Heska Corporation, Miltenyi Biotech GmbH, and PerkinElmer, Inc.

Small animal imaging involves devices and reagents used for preclinical imaging of rats and mice for the development of drugs, developmental studies, gene expression, and various other research activities in the field of oncology, neurology, cardiology, etc. These devices are similar to imaging modalities used for diagnostic purposes in humans, however due to the smaller size these are generally referred as micro devices.

Market Dynamics

Increasing focus of market key players in launching new devices for small animal imaging, making investments in R&D as well as on growth strategies such as mergers, collaborations, acquisitions, license and supply agreements, and others are expected to drive growth of the global small animal imaging market over the forecast period (2022-2030).

For instance, in October 2021, Fujifilm Medical Systems U.S.A., Inc. and Fujifilm Healthcare Americas Corporation (formerly Hitachi Healthcare Americas), both subsidiaries of Fujifilm Holding Corporation, announced a merger and the formation of Fujifilm Healthcare Americas Corporation. The new combined organization leverages each company's innovative product portfolios including small animal imaging devices such as optical imaging system, ultrasound imaging system, and others to create new value for customers and advance medical care.

Moreover, rising prevalence and incidence of chronic diseases such as cancer, diabetes, cardiovascular diseases, infectious diseases, etc. is expected to drive the global small animal imaging market growth over the forecast period.

For instance, according to data published in the Cancer Facts & Figures report by the American Cancer Society in January 2022, it is estimated that in 2022, around 1.9 million new cancer cases will be diagnosed and 609,360 cancer deaths will be reported in the U.S.

 Key features of the study:

  • This report provides an in-depth analysis of the global small animal imaging market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global small animal imaging market based on the following parameters – company overview, financial performance, Material portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Bruker, Aspect Imaging Ltd, TriFoil Imaging, LI-COR, Inc., FUJIFILM Holdings Corporation, Promega Corporation, Siemens Healthineers, Hallmarq Veterinary Imaging, Analytik Jena GmbH, Mediso Ltd., iThera Medical GmbH, MILabs B.V., Heska Corporation, Miltenyi Biotech GmbH, and PerkinElmer, Inc. 
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future Material launches, type up-gradation, market expansion, and marketing tactics
  • The global small animal imaging market report caters to various stakeholders in this industry including investors, suppliers, material manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small animal imaging market

Detailed Segmentation:

  • Global Small Animal Imaging Market, By Product Type:
    • Optical Imaging Systems
      • Bioluminescence/Fluorescence Imaging Systems
      • Standalone Fluorescence Imaging Systems
      • X-Ray/Optical Imaging Systems
    • Nuclear Imaging Systems
      • Micro-PET (Positron Emission Tomography) Systems
      • Micro-SPECT (Single-Photon Emission Computed Tomography) Systems
      • Trimodality (SPECT/PET/CT) Systems
    • MRI (Magnetic Resonance Imaging) Systems
    • Ultrasound Systems
    • CT (Computed Tomography) Systems
    • Others (Photoacoustic Imaging Systems and Magnetic Particle Imaging (MPI) Systems, among others)
  • Global Small Animal Imaging Market, By Application:
    • Monitoring Drug Treatment Response
    • Bio-distribution Studies
    • Cancer Cell Detection
    • Biomarkers
    • Others (Longitudinal Studies and Epigenetics, among others)
  • Global Small Animal Imaging Market, By End User:
    • Biotechnology and Pharmaceutical Companies
    • Academic/ Research Institutes 
    • Others (Contract Research Organizations, Laboratories, among others)
  • Global Small Animal Imaging Market, By Region:
    • North America
      •  
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Bruker*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Aspect Imaging Ltd
    • TriFoil Imaging
    • LI-COR, Inc.
    • FUJIFILM Holdings Corporation
    • Promega Corporation
    • Siemens Healthineers
    • Hallmarq Veterinary Imaging
    • Analytik Jena GmbH
    • Mediso Ltd.
    • iThera Medical GmbH
    • MILabs B.V.
    • Heska Corporation
    • Miltenyi Biotech GmbH
    • PerkinElmer, Inc. 

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

Global small animal imaging market size is estimated to be valued at US$ 977.7 million in 2022 and is expected to exhibit a CAGR of 7.1% between 2022 and 2030.
Rising number of cases of chronic diseases such as cancer, diabetes, etc. as well as rapid research and development activities for the development of novel small animal imaging products are expected to drive the market growth over the forecast period.
Optical Imaging Systems segment is expected to hold the major market share in the market.
North America holds the largest market share in the market.
Major factors hampering growth of the market include high device development cost for small animal imaging equipment and stringent regulatory scenario pertaining to the small animal imaging market
Major players operating in the market include Bruker, Aspect Imaging Ltd, TriFoil Imaging, LI-COR, Inc., FUJIFILM Holdings Corporation, Promega Corporation, Siemens Healthineers, Hallmarq Veterinary Imaging, Analytik Jena GmbH, Mediso Ltd., iThera Medical GmbH, MILabs B.V., Heska Corporation, Miltenyi Biotech GmbH, and PerkinElmer, Inc.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo